MEDICINE DETAILS
Takhzyro
Active ingredient: Lanadelumab
Neutral reference profile for an independent medicine-access consultancy enquiry about Takhzyro (Lanadelumab). No medicine is offered for sale.
NEXT STEP
Choose the strength and pack
✓ If you are unsure, choose “I do not know”.
These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.
ABOUT THIS MEDICINE
What is Takhzyro used for?
Takhzyro (lanadelumab) is a medicine for the prevention of recurrent attacks of hereditary angioedema (HAE) in patients aged 12 years and older. It is available as a solution for injection in single-dose, ready-to-use vials.
This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.
RECORDED PRODUCT PROFILE
Takhzyro identity, dosage form and pack information.
The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.
Recorded strength and pack options
Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.
-
150 mg · 1 pre-filled syringe Catalogue organisation: TAKEDA GmbH
-
300 mg · 1 pre-filled syringe Catalogue organisation: TAKEDA GmbH
-
300 mg · 2 pre-filled syringes Catalogue organisation: TAKEDA GmbH
-
300 mg · 6 pre-filled syringes Catalogue organisation: TAKEDA GmbH
-
300 mg solution for injection · 1 pen Catalogue organisation: TAKEDA GmbH
-
300 mg solution for injection · 2 pens Catalogue organisation: TAKEDA GmbH
-
300 mg solution for injection · 6 pens Catalogue organisation: TAKEDA GmbH
OFFICIAL SOURCES
Check the Takhzyro record at an official source.
Search for “Takhzyro” or “Lanadelumab”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.
OFFICIAL EXTERNAL SOURCE
European Medicines Agency (EMA)
Search medicines evaluated by EMA by brand name or active substance. EMA also links to national registers for nationally authorised products.
↗ OFFICIAL EXTERNAL SOURCE Drugs@FDASearch FDA-approved human drug records by brand name or active ingredient, including current labelling where available.
↗SERVICE BOUNDARY
Information checking and independent enquiry support for Takhzyro.
OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.
Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.
CLEAR ANSWERS
Frequently asked questions about Takhzyro
01What is Takhzyro?＋
This directory record associates the brand name Takhzyro with the active ingredient Lanadelumab. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.
02Which Takhzyro strengths and packs are recorded?＋
The catalogue currently shows: 150 mg · 1 pre-filled syringe; 300 mg · 1 pre-filled syringe; 300 mg · 2 pre-filled syringes; 300 mg · 6 pre-filled syringes. Check the complete strength, dosage form and pack description against the prescription and medicine box.
03Who manufactures Takhzyro?＋
Catalogue records currently name: TAKEDA GmbH. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.
04Do the listed options confirm stock or access?＋
No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.
05What affects a possible estimated medicine cost for Takhzyro?＋
A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Takhzyro, payment request, stock guarantee or binding offer.
06Can I buy Takhzyro from this website?＋
No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.